Clinical Study

Pregnancy Rate after Controlled Ovarian Hyperstimulation and Intrauterine Insemination for the Treatment of Endometriosis following Surgery

Table 1

Baseline characteristics of participants in the COH-IUI group () and the control group () at the Department of Obstetrics and Gynecology, University of Szeged, from January 2002 to December 2008.

Treatment group (COH-IUI) ()Control group () valueOR (95% CI)

Age (in years) (mean ± S.D.)33.5 ± 4.232.9 ± 4.4NS
Duration of menstrual cycle (days) (mean ± S.D.)27.2 ± 3.429.3 ± 6.2<0.05
Endometriosis
 Stage I or II48 (41.4%)50 (43.7%)NS0.95 (0.56–1.60)
 Stage III or IV68 (58.6%)67 (57.3%)
Body weight (kg) (mean ± S.D.)65.2 ± 7.364.0 ± 9.0NS
Body mass index (kg/m2) (mean ± S.D.)22.2 ± 1.921.9 ± 2.1NS
Duration of infertility (years) (mean ± S.D.)3.1 ± 2.12.9 ± 1.8NS
Sperm parameters of partner
 Sperm concentration (×106/mL)79.9 ± 11.077.2 ± 13.0NS
  Range21–13916–153NS
 Sperm motility (%)72.9 ± 4.077.1 ± 2.4NS
  Range67–8364–81NS
 Sperm morphology (%)57.8 ± 5.453.9 ± 3.7NS
  Range36–7531–75NS

COH-IUI: controlled ovarian hyperstimulation and intrauterine insemination; S.D.: standard deviation; OR: odds ratio, 95% CI: 95% confidence interval; NS: statistically not significant.